Related Experiment Video
Updated: Jul 11, 2025
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.6K
A software tool to adjust codeine dose based on CYP2D6 gene-pair polymorphisms and drug-drug interactions
1Pharmaceutical Sciences Department, School of Pharmacy, Lebanese American University, Byblos, Lebanon. ysaab@lau.edu.lb.
The Pharmacogenomics Journal
|November 8, 2023
Summary
A new tool helps doctors adjust codeine dosage by considering patient genetics (CYP2D6 variations) and drug interactions. This personalized approach aims to improve codeine
Area of Science:
- Pharmacogenomics
- Drug Metabolism
- Clinical Pharmacology
Background:
- Codeine metabolism is influenced by the CYP2D6 enzyme.
- Genetic variations in CYP2D6 lead to variable codeine efficacy and toxicity.
- Drug-drug interactions further complicate codeine dosing.
Purpose of the Study:
- To develop a tool for adjusting codeine dosage.
- To incorporate CYP2D6 gene-pair polymorphisms and drug-drug interactions into dosing recommendations.
- To provide a framework for individualized codeine dosing.
Main Methods:
- Development of a dosing adjustment tool.
- Integration of pharmacogenetic data (CYP2D6 polymorphisms).
- Inclusion of drug-drug interaction data.
Main Results:
- The study presents a tool to assist prescribers in codeine dose adjustment.
- The tool considers CYP2D6 gene-pair polymorphisms.
- The tool accounts for potential drug-drug interactions.
Conclusions:
- Individualized codeine dosing requires consideration of pharmacogenetics and drug-drug interactions.
- The developed tool supports personalized medicine in codeine prescription.
- Clinical judgment remains essential alongside the tool for optimal patient care.
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
267
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
267
01:15Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
163
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
163
01:11Renal Failure: Dose Adjustments
96
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
96
01:14Drug Metabolism: Phase II Reactions
3.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.9K
01:01Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K